2013Linchuang gandanbing zazhiRequires access

Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension

Yongsheng Chen

Open publisher page 0 citations

Abstract

Objective To investigate the clinical efficacy and therapeutic value of partial splenic artery embolization(PSE) for treating portal hypertension in patients with liver cirrhosis.Methods Twenty-three patients diagnosed with liver cirrhosis of different etiology and with portal hypertension were treated with PSE.Diameter and blood flow velocity of the portal vein(PV) and splenic vein(SV) were measured by color Doppler ultrasound before PSE(baseline) and after PSE(postoperative week 1 and months 1,3,and 6).Statistical significance of differences was assessed by paired t-test.Results Both the PV and SV blood flow velocities were significantly enhanced after PSE(all postoperative times vs.baseline,P0.05).SV diameter was significantly reduced after PSE(all postoperative times vs.baseline,P0.05).PV diameter,however,was not significantly reduced at six months after PSE(vs.baseline,P≥0.05).Conclusion PSE can reduce portal vein pressure in patients with liver cirrhosis.

About this research paper

What this paper is about

Objective To investigate the clinical efficacy and therapeutic value of partial splenic artery embolization(PSE) for treating portal hypertension in patients with liver cirrhosis.Methods Twenty-three patients diagnosed with liver cirrhosis of different etiology and with portal hypertension were treated with PSE.Diameter and blood flow velocity of the portal vein(PV) and splenic vein(SV) were measured by color Doppler ultrasound before PSE(baseline) and after PSE(postoperative week 1 and months 1,3,and 6).Statistical significance of differences was assessed by paired t-test.Results Both the PV and SV blood flow velocities were significantly enhanced after PSE(all postoperative times vs.baseline,P0.05).SV diameter was significantly reduced after PSE(all postoperative times vs.baseline,P0.05).PV diameter,however,was not significantly reduced at six months after PSE(vs.baseline,P≥0.05).Conclusion PSE can reduce portal vein pressure in patients with liver cirrhosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical efficacy and therapeutic value of partial splenic artery embolization(PSE) for treating portal hypertension in patients with liver cirrhosis.Methods Twenty-three patients diagnosed with liver cirrhosis of different etiology and with portal hypertension were treated with PSE.Diameter and blood flow velocity of the portal vein(PV) and splenic vein(SV) were measured by color Doppler ultrasound before PSE(baseline) and after PSE(postoperative week 1 and months 1,3,and 6).Statistical significance of differences was assessed by paired t-test.Results Both the PV and SV blood flow velocities were significantly enhanced after PSE(all postoperative times vs.baseline,P0.05).SV diameter was significantly reduced after PSE(all postoperative times vs.baseline,P0.05).PV diameter,however,was not significantly reduced at six months after PSE(vs.baseline,P≥0.05).Conclusion PSE can reduce portal vein pressure in patients with liver cirrhosis.

Key concepts: Medicine, Cirrhosis, Portal hypertension, Splenic artery, Splenic vein, Portal venous pressure, Blood flow, Embolization

Related papers

Back to paper searchBrowse research topicsOriginal source
Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension — Research Paper | ScholarLens